Changeflow GovPing Healthcare & Life Sciences OAB Mixed-Methods Multi-country PROMs Quality o...
Routine Notice Added Final

OAB Mixed-Methods Multi-country PROMs Quality of Life Study NCT07545148

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

NCT07545148 is an observational clinical trial registry entry for a mixed-methods, multi-country study examining patient-reported outcomes and quality of life in individuals living with Overactive Bladder (OAB). The study aims to understand OAB's lived burden across daily activities, emotional wellbeing, mental health, social life, relationships, and work. Registered on ClinicalTrials.gov by the National Library of Medicine, this trial collects no biological samples and focuses on qualitative and quantitative patient experience data.

“The main goal is to understand what it is truly like to live with OAB from the patient's perspective, including how it affects: daily activities, emotional wellbeing and mental health, social life and relationships, work and overall quality of life.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors ClinicalTrials.gov Studies for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 686 changes logged to date.

What changed

This registry entry documents a new observational clinical trial focused exclusively on patient-reported outcome measures (PROMs) for Overactive Bladder. The study is classified as observational with no interventional components, targeting OAB patients across multiple countries to capture qualitative and quantitative data on quality of life impacts. Clinical investigators, healthcare providers, and pharmaceutical companies developing OAB therapies may find these PROMs data relevant to understanding patient burden and treatment outcomes in real-world settings.

The registration does not create compliance obligations but serves as a public record of ongoing research. Sponsors of OAB-related therapeutic products should monitor this study for potential impact on label expansion, comparative effectiveness research, or patient-centered outcome development. Healthcare researchers conducting similar PROMs work may reference NCT07545148 methodology for study design alignment.

Archived snapshot

Apr 22, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Real-world Experiences and Voices Exploring the Actual Lived Burden of OAB: A Mixed-methods Multi-country PROMs Study on OAB Patients' Quality of Life

Observational NCT07545148 Kind: OBSERVATIONAL Apr 22, 2026

Abstract

The main goal is to understand what it is truly like to live with OAB from the patient's perspective, including how it affects: daily activities, emotional wellbeing and mental health, social life and relationships, work and overall quality of life.

Conditions: Overactive Bladder (OAB), Overactive Bladder Syndrome

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 22nd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Clinical investigators Healthcare providers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Clinical trial registration Observational study Patient-reported outcomes
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!